公开(公告)号：US20170128722A1

公开(公告)日：2017-05-11

申请号：US15337321

申请日：2016-10-28

申请人： Elira Therapeutics LLC

发明人： Raul E. Perez

IPC分类号： A61N1/36 ,  A61B5/0476 ,  A61B5/0488 ,  A61B5/053 ,  A61B5/0408 ,  A61B5/0402 ,  A61B5/021 ,  A61B5/08 ,  A61B5/145 ,  A61B5/1455 ,  A61N1/04 ,  A61B5/00

摘要： A wearable device for treating dysmenorrhea in a patient includes a microprocessor, electrical stimulator and at least one electrode configured to deliver electrical stimulation from the external surface of the patient's epidermal layer through a range of 0.1 mm to 10 mm or a range of 0.1 mm to 20 mm of the dermis by applying electrical stimulation to the epidermis of a T9 to T12, L1, L2, L5 and/or S1 to S4 dermatomes of the patient. The device includes a pad, in which the electrode is disposed, for secure placement of the device on a skin surface of the patient. The device is adapted to provide electrical stimulation as per stimulation protocols and to communicate wirelessly with a companion control device configured to monitor and record menstruation-related patterns of the patient. The control device is also configured to monitor, record, and modify stimulation parameters of the stimulation protocols.

公开(公告)号：US20170021171A1

公开(公告)日：2017-01-26

申请号：US15052784

申请日：2016-02-24

申请人： Elira Therapeutics LLC

发明人： Raul E. Perez ,  Paul V. Goode ,  Peter I. Hong ,  Steven Diianni ,  Luis Jose Malave ,  Brad Stengel ,  John L. Faul

IPC分类号： A61N1/36 ,  A61N1/04

CPC分类号： A61N1/36014 ,  A61B5/0024 ,  A61B5/02055 ,  A61B5/02405 ,  A61B5/0245 ,  A61B5/04 ,  A61B5/0537 ,  A61B5/1118 ,  A61B5/14532 ,  A61B5/42 ,  A61B5/4211 ,  A61B5/4848 ,  A61B5/4866 ,  A61B5/6832 ,  A61B5/7475 ,  A61N1/0456 ,  A61N1/0476 ,  A61N1/0484 ,  A61N1/0492 ,  A61N1/08 ,  A61N1/36007 ,  A61N1/36128 ,  A61N1/37211 ,  A61N1/37235 ,  A61N2001/083 ,  G06F19/00

摘要： A wearable device for suppressing appetite or hunger in a patient includes a microprocessor, electrical stimulator and at least one electrode configured to deliver electrical stimulation to the epidermis, through a range of 0.1 mm to 10 mm or a range of 0.1 mm to 20 mm of the dermis, of a T2 frontal thoracic dermatome to a T12 frontal thoracic dermatome or meridian of the patient and/or front or back, C5-T1 dermatome across the hand and/or arm, and/or the upper chest regions. The device includes a pad, in which the electrode is disposed, for secure placement of the device on a skin surface of a patient. The device is adapted to provide electrical stimulation as per stimulation protocols and to communicate wirelessly with a companion control device configured to monitor and record appetite patterns of the patient. The control device is also configured to monitor, record, and modify stimulation parameters of the stimulation protocols.

摘要翻译： 用于抑制患者的食欲或饥饿的穿戴式装置包括微处理器，电刺激器和至少一个电极，其被配置为将电刺激递送至表皮，其范围为0.1mm至10mm或0.1mm至20mm的范围 T2正面胸廓皮肤真皮与T12额叶胸廓皮层或患者和/或前或后的C5-T1皮肤穿过手和/或臂和/或上胸部区域的真皮。 该装置包括垫，其中布置有电极，用于将装置牢固地放置在患者的皮肤表面上。 该装置适于根据刺激协议提供电刺激，并且与被配置为监测和记录患者的胃口模式的伴随控制装置无线通信。 控制装置还被配置为监测，记录和修改刺激方案的刺激参数。

公开(公告)号：US20170021172A1

公开(公告)日：2017-01-26

申请号：US15052791

申请日：2016-02-24

申请人： Elira Therapeutics LLC

发明人： Raul E. Perez ,  Paul V. Goode ,  Peter I. Hong ,  Steven Diianni ,  Luis Jose Malave ,  Brad Stengel ,  John L. Faul

IPC分类号： A61N1/36 ,  A61N1/08 ,  A61N1/04

CPC分类号： A61N1/36014 ,  A61B5/0024 ,  A61B5/02055 ,  A61B5/02405 ,  A61B5/0245 ,  A61B5/04 ,  A61B5/0537 ,  A61B5/1118 ,  A61B5/14532 ,  A61B5/42 ,  A61B5/4211 ,  A61B5/4848 ,  A61B5/4866 ,  A61B5/6832 ,  A61B5/7475 ,  A61N1/0456 ,  A61N1/0476 ,  A61N1/0484 ,  A61N1/0492 ,  A61N1/08 ,  A61N1/36007 ,  A61N1/36128 ,  A61N1/37211 ,  A61N1/37235 ,  A61N2001/083 ,  G06F19/00

摘要： A wearable device for suppressing appetite or hunger in a patient includes a microprocessor, electrical stimulator and at least one electrode configured to deliver electrical stimulation to the epidermis, through a range of 0.1 mm to 10 mm or a range of 0.1 mm to 20 mm of the dermis, of a T2 frontal thoracic dermatome to a T12 frontal thoracic dermatome or meridian of the patient and/or front or back, C5-T1 dermatome across the hand and/or arm, and/or the upper chest regions. The device includes a pad, in which the electrode is disposed, for secure placement of the device on a skin surface of a patient. The device is adapted to provide electrical stimulation as per stimulation protocols and to communicate wirelessly with a companion control device configured to monitor and record appetite patterns of the patient. The control device is also configured to monitor, record, and modify stimulation parameters of the stimulation protocols.